Stock BSGM BIOSIG TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Market Closed - Nasdaq
Other stock markets
 21:00:00 09/05/2024 BST 		5-day change 1st Jan Change
1.28 USD +0.79% Intraday chart for BioSig Technologies, Inc. -28.09% -73.05%
05-03 BioSig Technologies, Inc. Announces Board Appointments CI
04-30 BioSig Technologies, Inc. Appoints Anthony Amato as Chief Executive Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent  
AQ
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
AQ
BioSig Technologies : Annual report pursuant to Section 13 and 15(d)
PU
BioSig Engages Consulting Firm for Business Model Strategies
AQ
BioSig Technologies : Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
PU
BioSig Technologies : Failure to Satisfy Listing Rule - Form 8-K
PU
BioSig Announces Reduction of its Workforce
AQ
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
AQ
BioSig Announces Reverse Stock Split
GL
BioSig Announces Reverse Stock Split
AQ
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
GL
BioSig Technologies : Corporate Summary
PU
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
GL
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
AQ
BioSig Technologies : Corporate Summary
PU
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GL
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GL
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
AQ
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
GL
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BSGM Stock
  4. News BioSig Technologies, Inc.
  5. Press Releases